PIOGLITAZON ACTAVIS
15MG TBL NOB 28 KAL
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Resumption of marketing | 17.05.2022 | |||
| Interruption of marketing | 19.05.2022 |
0221773, 0233298 |
Capacity/distribution reasons | 30.06.2022 |
| Resumption of marketing | 21.01.2021 | |||
| Interruption of marketing | 17.09.2020 |
0193077, 0233298, 0026304 Dle indikací |
Manufacturing reasons | 30.09.2020 |
| Resumption of marketing | 01.10.2019 | |||
| Interruption of marketing | 30.09.2019 |
0193077, 0026304 |
Manufacturing reasons | Nelze stanovit |
| Placing on the market | 01.06.2012 |
All reports are available in the Overview.
cz